Skip to content

Clinical trials

Phase 3 Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 3 Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20083
20121
20131
20141
20161
20174
20193
20201
20213
20226
20233
20242
20252
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting11
Unknown status3
Terminated3
Active, not recruiting3
Not yet recruiting2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim10
United Therapeutics4
Insmed Incorporated3
Actelion2
Assistance Publique - Hôpitaux de Paris2
GlaxoSmithKline2
Kyntra Bio2
AstraZeneca1
Bristol-Myers Squibb1
Dr. Denis O'Donnell1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial43
Idiopathic Pulmonary Fibrosis8
Scleroderma, Diffuse6
Hypertension, Pulmonary5
Pulmonary Fibrosis5
Connective Tissue Diseases4
Fibrosis4
Scleroderma, Systemic4
Cardiovascular Diseases3
Lung Diseases3

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.